Indian negotiators flew home Saturday after a fifth round of talks in Washington, but the long-trailed “mini deal” is now “likely by September-October.” Talks wrapped July 17 and spanned agriculture, automobiles, and high-tech exports under the SCOMET list but no deal still in place.
“India is close to finalising an interim free trade agreement with the United States,” NDTV reported, adding that “an announcement is expected by September or October.” The delay leaves New Delhi staring at President Donald Trump’s August 1 tariff deadline without a signed shield.
🚨 INDIA TRADE TEAM BACK TO INDIA, DEAL WITH US LIKELY BY SEPTEMBER-OCTOBER – NDTV
— *Walter Bloomberg (@DeItaone) July 21, 2025
Those emergency power tariffs—up to 26% on a swath of imports—remain under appeal. India also wants relief from the 50% hit on steel and aluminium and the 25% rate on autos. New Delhi’s negotiators pushed hard for broader market access on labour-intensive exports: textiles, gems, leather goods, shrimp, grapes, bananas.
Washington’s shopping list is equally specific. Duty concessions on electric vehicles, wines, petrochemicals, plus a basket of agricultural and genetically modified products. In short: the White House wants quicker entry for US scale industries and farm lobbies, which Trump’s advisers can sell as “reciprocity.” However, India sees it as one-sided unless steel and textile pain is removed in tandem.
Both capitals now frame this as “phase one” of a broader bilateral trade agreement. The interim piece is triage: stop a tariff spiral that could ricochet through apparel, leather, and even pharmaceuticals if retaliation kicks in.
The next milestone is mid-August, when a US team lands in Delhi to keep the interim draft moving. If language is locked by then, signatures in September are plausible. If not, the “mini deal” becomes a winter story and a bigger tariff shock becomes a base case.
Information for this briefing was found via NDTV and the sources mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.